Trials / Completed
CompletedNCT00921752
C2 -CORVUS Cholesterol-Control (C2) Controlled Targets for High Vascular Risk Patients Using Effective Statins (CORVUS)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,500 (estimated)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To demonstrate a higher percent rate of achieved target lipid goals among patients at high cardiovascular risk using more potent lipid-lowering treatment options including high-potency statins and combination therapies.
Conditions
Timeline
- Start date
- 2009-05-01
- Completion
- 2009-11-01
- First posted
- 2009-06-16
- Last updated
- 2009-12-04
Locations
26 sites across 1 country: Hungary
Source: ClinicalTrials.gov record NCT00921752. Inclusion in this directory is not an endorsement.